Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping

被引:20
作者
Deborde, E. [1 ,2 ]
Dubourg, B. [1 ,3 ,4 ]
Bejar, S. [1 ]
Brehin, A-C [5 ]
Normant, S. [1 ]
Michelin, P. [1 ]
Dacher, J-N [1 ,3 ,4 ]
机构
[1] Univ Hosp Rouen, Dept Radiol, F-76031 Rouen, France
[2] Univ Hosp Strasbourg, Dept Radiol, F-67098 Strasbourg, France
[3] INSERM, UFR Med Pharm, U1096, F-76183 Rouen, France
[4] Univ Rouen, Inst Res & Innovat Biomed, F-76000 Rouen, France
[5] Univ Hosp Rouen, Dept Genet, F-76031 Rouen, France
关键词
Cardiac magnetic resonance imaging (MRI); Fabry disease; Left ventricular hypertrophy; Hypertrophic cardiomyopathy; CARDIOVASCULAR MAGNETIC-RESONANCE; ENZYME REPLACEMENT THERAPY; LOOK-LOCKER; HEART; MOLLI; PREVALENCE; MRI;
D O I
10.1016/j.diii.2019.08.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the potential of non-contrast myocardial T1 mapping on cardiovascular magnetic resonance examination (CMR) in differentiating patients with Fabry disease (FD) from those with hypertrophic cardiomyopathy (HCM) and healthy control subjects. Materials and methods: Seventeen patients with FD (8 men, 9 women; mean age, 48 years +/- 18 [range: 19-73 years]; 53% with left ventricular hypertrophy [LVH]) were matched with 36 patients with hypertrophic cardiomyopathy (HCM) (22 men, 14 women; mean age, 57 years +/- 16 [SD] [range: 22-85 years]) and 70 healthy control subjects (34 men, 36 women; mean age, 38 years +/- 15 [SD]; [range: 18-65 years]). Cardiac T1 mapping was performed using the modified Look-Locker inversion (MOLLI (R)) sequence on a 1.5-T magnet. T1 values were calculated, on mid-ventricular section, for septal left ventricular segments (S8-S9) and all mid-ventricular ones (global T1 values; S7-S12). Statistical analysis included unpaired Mann-Whitney test, receiver operating characteristic curve and likelihood ratios. Results: Septal native T1 values were significantly decreased in patients with AFD (889 +/- 61 [SD] ms; range: 784-980 ms) compared to those with HCM (995 + 48 [SD] ms; range: 935-1125 ms) P< 0.001) and versus healthy controls (965 +/- 29 [SD] ms; range: 910-1028 ms) (P< 0.001). Global native T1 values were also significantly decreased in patients with AFD (891 +/- 49 [SD] ms; range 794-970 ms) compared to those with HCM (995 +/- 34 [SD] ms; range: 952-1086 ms) (P < 0.001) and versus healthy controls (966 +/- 27 [SD] ms; range: 920-1042 ms) (P < 0.001). A septal left ventricular native T1 cutoff value of 940 ms could distinguish AFD from HCM with 88% sensitivity (95% CI: 73-100%) and 92% specificity (95% CI: 83-100%). Positive likelihood ratio was 11, negative likelihood ratio was 0.12. Compared to controls, the same threshold could distinguish AFD with 88% sensitivity (95% CI: 73-100%) and 86% specificity (95% CI: 78-94%). Positive likelihood ratio was 6.3, negative likelihood ratio was 0.14. T1 value was abnormal in 4 of 8 (50%) of FD patients who did not have LVH. Conclusion: Native T1 values are significantly lower in patients with AFD compared with HCM and healthy volunteers. (C) 2019 Societe francaise de radiologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 41 条
[11]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[12]   Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR [J].
Fontana, Marianna ;
White, Steve K. ;
Banypersad, Sanjay M. ;
Sado, Daniel M. ;
Maestrini, Viviana ;
Flett, Andrew S. ;
Piechnik, Stefan K. ;
Neubauer, Stefan ;
Roberts, Neil ;
Moon, James C. .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2012, 14
[13]   2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
Gersh, Bernard J. ;
Maron, Barry J. ;
Bonow, Robert O. ;
Dearani, Joseph A. ;
Fifer, Michael A. ;
Link, Mark S. ;
Naidu, Srihari S. ;
Nishimura, Rick A. ;
Ommen, Steve R. ;
Rakowski, Harry ;
Seidman, Christine E. ;
Towbin, Jeffrey A. ;
Udelson, James E. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) :E212-E260
[14]   Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa [J].
Hughes, D. A. ;
Elliott, P. M. ;
Shah, J. ;
Zuckerman, J. ;
Coghlan, G. ;
Brookes, J. ;
Mehta, A. B. .
HEART, 2008, 94 (02) :153-158
[15]   The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure [J].
Karamitsos, Theodoros D. ;
Francis, Jane M. ;
Myerson, Saul ;
Selvanayagam, Joseph B. ;
Neubauer, Stefan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (15) :1407-1424
[16]   Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy [J].
Karur, Gauri R. ;
Robison, Sean ;
Iwanochko, Robert M. ;
Morel, Chantal F. ;
Crean, Andrew M. ;
Thavendiranathan, Paaladinesh ;
Nguyen, Elsie T. ;
Mathur, Shobhit ;
Wasim, Syed ;
Hanneman, Kate .
RADIOLOGY, 2018, 288 (02) :398-406
[17]   T1 and extracellular volume mapping in the heart: estimation of error maps and the influence of noise on precision [J].
Kellman, Peter ;
Arai, Andrew E. ;
Xue, Hui .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2013, 15
[18]   Prognostic Value of Routine Cardiac Magnetic Resonance Assessment of Left Ventricular Ejection Fraction and Myocardial Damage An International, Multicenter Study [J].
Klem, Igor ;
Shah, Dipan J. ;
White, Richard D. ;
Pennell, Dudley J. ;
van Rossum, Albert C. ;
Regenfus, Matthias ;
Sechtem, Udo ;
Schvartzman, Paulo R. ;
Hunold, Peter ;
Croisille, Pierre ;
Parker, Michele ;
Judd, Robert M. ;
Kim, Raymond J. .
CIRCULATION-CARDIOVASCULAR IMAGING, 2011, 4 (06) :610-619
[19]   Heart in Anderson-Fabry disease and other lysosomal storage disorders [J].
Linhart, Ales ;
Elliott, Perry M. .
HEART, 2007, 93 (04) :528-535
[20]   Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects [J].
Liu, Joanna M. ;
Liu, Alexander ;
Leal, Joana ;
McMillan, Fiona ;
Francis, Jane ;
Greiser, Andreas ;
Rider, Oliver J. ;
Myerson, Saul ;
Neubauer, Stefan ;
Ferreira, Vanessa M. ;
Piechnik, Stefan K. .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2017, 19